Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Tacchetti

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Blood|December 28, 2018
Imaging in multiple myeloma: How? When?Elena Zamagni, Paola Tacchetti, Michele Cavo
Hemasphere|March 21, 2022
Front-line treatment of multiple myelomaMichele Cavo, Paola Tacchetti, Elena Zamagni
Lancet (London, England)|June 7, 2021
Expanding CD38-targeting triplets for relapsed or refractory multiple myelomaMichele Cavo, Paola Tacchetti, Elena Zamagni
Expert Review of Hematology|March 28, 2018
Anti-CD38 and anti-SLAMF7: the future of myeloma immunotherapyElena Zamagni, Paola Tacchetti, Lucia Pantani, et al.
Expert Review of Anticancer Therapy|March 4, 2014
Maintenance therapy in newly diagnosed multiple myeloma: current recommendationsAnnamaria Brioli, Paola Tacchetti, Elena Zamagni, et al.
Journal of Clinical Medicine|November 4, 2020
Role of Imaging in the Evaluation of Minimal Residual Disease in Multiple Myeloma PatientsElena Zamagni, Paola Tacchetti, Simona Barbato, et al.
Cancers|July 13, 2024
Bispecific Antibodies for the Management of Relapsed/Refractory Multiple MyelomaPaola Tacchetti, Simona Barbato, Katia Mancuso, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|January 3, 2015
Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myelomaEnrica Borsi, Carolina Terragna, Annamaria Brioli, et al.
Seminars in Thrombosis and Hemostasis|April 2, 2011
Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosisElena Zamagni, Annamaria Brioli, Paola Tacchetti, et al.
Expert Opinion on Biological Therapy|December 9, 2024
Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myelomaKatia Mancuso, Simona Barbato, Marco Talarico, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Blood|December 28, 2018
Imaging in multiple myeloma: How? When?Elena Zamagni, Paola Tacchetti, Michele Cavo
Hemasphere|March 21, 2022
Front-line treatment of multiple myelomaMichele Cavo, Paola Tacchetti, Elena Zamagni
Lancet (London, England)|June 7, 2021
Expanding CD38-targeting triplets for relapsed or refractory multiple myelomaMichele Cavo, Paola Tacchetti, Elena Zamagni
Expert Review of Hematology|March 28, 2018
Anti-CD38 and anti-SLAMF7: the future of myeloma immunotherapyElena Zamagni, Paola Tacchetti, Lucia Pantani, et al.
Expert Review of Anticancer Therapy|March 4, 2014
Maintenance therapy in newly diagnosed multiple myeloma: current recommendationsAnnamaria Brioli, Paola Tacchetti, Elena Zamagni, et al.
Journal of Clinical Medicine|November 4, 2020
Role of Imaging in the Evaluation of Minimal Residual Disease in Multiple Myeloma PatientsElena Zamagni, Paola Tacchetti, Simona Barbato, et al.
Cancers|July 13, 2024
Bispecific Antibodies for the Management of Relapsed/Refractory Multiple MyelomaPaola Tacchetti, Simona Barbato, Katia Mancuso, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|January 3, 2015
Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myelomaEnrica Borsi, Carolina Terragna, Annamaria Brioli, et al.
Seminars in Thrombosis and Hemostasis|April 2, 2011
Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosisElena Zamagni, Annamaria Brioli, Paola Tacchetti, et al.
Expert Opinion on Biological Therapy|December 9, 2024
Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myelomaKatia Mancuso, Simona Barbato, Marco Talarico, et al.
Pageof 10